Sometimes it's just public relations. We subsidize nicotine patches but regulators are increasingly interested in banning electronic cigarettes.

Such misguided legislation, not backed by sound data, may have consequences for public health, experts say. With smoking blamed for up to six million premature deaths each year, a lot is at stake in the newest push for regulations.

Tar, chemicals, and other substances found in tobacco smoke cause most of the health risks from cigarettes, not nicotine. That's why patches work and marketing campaigns using tax dollars endorse patches. Likewise, e-cigarettes deliver nicotine without the smoke. Yet despite users seeing the clear benefit from e-cigarettes, members of the health community, pharmaceutical regulators and governments have voiced concerns. Fears include e-cigarettes encouraging higher nicotine consumption than traditional cigarettes, and perpetuating addiction rather than promoting quitting, though no one takes up nicotine patches and then migrates to cigarettes.

Potential health effects from long-term e-cigarette use are unknown, unlike marijuana, which is well-documented even without the lung damage but is enjoying a golden age of popular approval. Yet despite any evidence, detractors claim these products will appeal to young non-smokers and make smoking publicly acceptable. The authors of the article argue that these claims are speculative but are often cited in moves to restrict e-cigarettes.

The authors show that efforts to address these concerns without sound data can lead to unintended consequences: the first draft of the revision of the European Union (EU) legislation proposed in December 2012 attempted to define arbitrary limits to the nicotine content in the liquid of e-cigarettes, a clear indicator of the poor understanding of the problem by legislators.. Only a few months later, the same EU health ministers proposed distinctive amendments to the first draft applying substantial pharmaceutical regulations to e-cigarettes– a move that was rejected by the EU Parliament in October 2013. This would have resulted in higher costs and limiting access (sale via pharmacies only) to consumers. The authors say, "It is counter-productive and hypocritical to over-regulate a product designed to reduce or eliminate the diseases and early deaths caused by smoking."

The UK's Medicines and Healthcare Regulatory Agency (MHRA) has moved towards regulating e-cigarettes as medical products - meaning cigarettes are legal but substitutes are not, a move sure to promote cigarettes. In Canada, electronic products that dispense nicotine by inhalation fall under the Food and Drugs Act of the Health Canada, which means it is illegal to smoke e-cigarettes, and stipulates that it must be approved as a new drug before they can be sold or imported.

Daniela Saitta, Giancarlo Antonio Ferro and Riccardo Polosa from the University of Catania propose that e-cigarette regulators should consider:

Evidence that good manufacturing practices (GMP) have been followed

Child-proof caps on fluid containers

Official documentation reporting on the contents of e-cigarette fluids to regulators

Clear, accurate and detailed labeling about the contents and the hazards associated with e-cigarette use.

Moreover, regulatory frameworks for electronic products are already available in the EU legislation to cover for the safety issues regarding E-cigarettes' hardware components. The authors note that such legislation may be "impossible to implement" due to the interests of tobacco and pharmaceutical industries, and, of course, that governments have increasingly raised taxes on cigarettes, making social services more reliant on that revenue.

"If these obstacles can be overcome, much misery and suffering can be reduced and millions of lives can be saved," the authors declare. "E-cigarettes are not a gateway to smoking but a gateway from smoking, and heavy regulation by restricting access to e-cigarettes would just encourage continuing use of much unhealthier tobacco smoking."

Article: "Achieving appropriate regulations for electronic cigarettes", Therapeutic Advances in Chronic Disease.